Open AccessCan artificial intelligence identify effective COVID ‐19 therapies?
Author(s) -
Schultz Michael B,
Vera Daniel,
Sinclair David A
Publication year - 2020
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.202012817
Subject(s) - covid-19 , virology , computational biology , medicine , chemistry , biology , infectious disease (medical specialty) , disease , outbreak
In this issue of EMBO Molecular Medicine , Stebbing et al (2020b) validate an artificial intelligence‐assisted prediction that a drug used to treat rheumatoid arthritis could be a potent weapon against COVID ‐19. Using liver organoids infected with SARS ‐CoV‐2, they confirm dual antiviral and anti‐inflammatory activities and show that its administration in four COVID ‐19 patients is correlated with disease improvement, paving the way for more rigorous placebo‐controlled trials.